ClinicalTrials.gg
Enrolling by invitationNCT07547579Updated Apr 23, 2026

The Effect of Neonatal Care Education Given to Primiparous Mothers in the Last Trimester on Mothers' Self-Efficacy Perception, Prenatal and Maternal Bonding in the Early Postpartum Period

An interventional study of Newborn Care Education in Primiparous Pregnant Women in the Last Trimester, sponsored by Kafkas University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Kafkas University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Apr 2024, registered Jan 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This study was conducted using a pre-test-post-test randomized controlled experimental design to investigate the effects of neonatal care education given to primiparous mothers in the last trimester on their self-efficacy perception, prenatal and maternal bonding in the early postpartum period. The study population consisted of pregnant women in the last trimester who applied to the Antenatal School of Kars Harakani State Hospital between November 2024 and November 2026. The study sample consisted of a total of 76 pregnant women, divided into an intervention group (n: 38) and a control group (n: 38). Data were collected using the "Personal Information Form", "General Self-Efficacy Scale", "Prenatal Attachment Inventory", and "Maternal Attachment Scale". The intervention group received training on newborn care. In the first phase of the study, a pre-test was administered to both the intervention and control groups. Following the pre-test, Newborn Care Training was conducted face-to-face with pregnant women in the experimental group in two 20-minute sessions, totaling 40 minutes, after which the pregnant women were given an educational booklet. After this training session, reinforcement training was conducted twice by telephone at one-week intervals, and their questions were answered. After the pre-test, at 36 weeks of gestation, both the intervention and control groups were contacted by telephone and the "General Self-Efficacy Scale" and "Prenatal Attachment Inventory" were administered as post-tests. Six weeks after delivery, the maternal attachment scale was administered to both the intervention and control groups.

02

Conditions studied

  • Primiparous Pregnant Women in the Last Trimester

Keywords

  • PREGNANCY, NEWBORN, PRENATAL, MATERNAL, SELF-EFFICACY
03

In context

Lead sponsor

Kafkas University is the lead sponsor of 32 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Being over 18 and under 35 years of age, Being in the last trimester of pregnancy (28-32 weeks of gestation) Having no communication barriers and being literate Single pregnancy Spontaneous conception Having applied to the Kars Harakani State Hospital Pregnancy School Agreeing to participate in the study

Exclusion criteria

Exclusion Criteria:

Chronic illness, High-risk pregnancy, Having a psychological disorder, Having applied to a Pregnancy School other than Harakani State Hospital.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2 participants (estimated)

Study arms

  • Active comparator
    Intervention Group Intervention Type: Behavioral Name: Newborn Care Education Group

    Primiparous women in their third trimester assigned to the intervention group will receive a structured newborn care education program in addition to completing the study questionnaires.

    Behavioral: Newborn Care Education

  • No intervention
    Control Group

    Primiparous women assigned to the control group will receive routine prenatal care and will complete the study questionnaires only.

Interventions

  • BehavioralNewborn Care Education

    The newborn care education program includes information on breastfeeding, infant hygiene, umbilical cord care, infant safety, and basic newborn care practices. The education is provided during the third trimester of pregnancy. Allocation / Randomization Allocation: Randomized Randomization Description: Participants will be randomly assigned to the intervention group or the control group using a computer-generated randomization sequence with a 1:1 allocation ratio. Masking (Blinding) Masking: None (Open Label) Masking Description (opsiyonel): This is an open-label study. Participants and investigators are aware of group assignment.

06

What researchers measure

Primary outcomes

  1. General Self-Efficacy

    Changes in maternal self-efficacy levels measured using the General Self-Efficacy Scale during the early postpartum period.

    Time frame: (between 24 and 41 weeks of pregnancy)

Secondary outcomes

  1. Prenatal Attachment

    Changes in prenatal attachment levels measured using the Prenatal Attachment Inventory.

    Time frame: (between 24 and 41 weeks of pregnancy)

  2. Maternal Attachment

    Maternal attachment levels measured using the Maternal Attachment Scale during the early postpartum period.

    Time frame: 6th week after birth

07

Study locations

1 site
  • Kafkas Üniversitesi
    Kars, Merkez 36100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — The privacy of personal data is respected in this study. Voluntary informed consent forms are obtained from participants. Therefore, the researcher does not share the participants' information.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2024 (actual). Primary completion is estimated for Dec 2026, 32 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2026
First posted
Apr 23, 2026
StartActual
Apr 1, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Apr 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07547579
Lead sponsor
Kafkas University
Responsible party
YAĞMUR KOTANCI (PhD Student, Kafkas University) — Principal investigator
First posted
Apr 23, 2026
Start date
Apr 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion